GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,961,000 | -3.2% | 28,570 | -20.5% | 0.75% | +0.7% |
| Q2 2019 | $2,025,000 | +29.0% | 35,942 | +45.7% | 0.74% | +6.6% |
| Q1 2019 | $1,570,000 | 0.0% | 24,665 | 0.0% | 0.70% | +3.7% |
| Q4 2018 | $1,570,000 | -34.3% | 24,665 | -28.4% | 0.67% | -18.2% |
| Q3 2018 | $2,391,000 | +31.8% | 34,459 | -5.1% | 0.82% | +22.2% |
| Q2 2018 | $1,814,000 | – | 36,293 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |